It is important to note that, in a similar manner to that reported with FFAR2, the reduced expression of HCAR2 associated to colon cancer, difficult the potential beneficial effects of the activation of this receptor on tumor progression. The gene discussed is FFAR2; the disease is malignant colon neoplasm.